• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

经皮冷冻消融治疗肝肿瘤后凝血功能障碍的诊断与治疗:372 例患者的经验。

Diagnosis and treatment of coagulopathy following percutaneous cryoablation of liver tumors: experience in 372 patients.

机构信息

Fuda Cancer Hospital, Jinan University School of Medicine, No. 2 Tangdexi Road, Tianhe District, Guangzhou 510665, China.

出版信息

Cryobiology. 2013 Oct;67(2):146-50. doi: 10.1016/j.cryobiol.2013.06.004. Epub 2013 Jul 4.

DOI:10.1016/j.cryobiol.2013.06.004
PMID:23830952
Abstract

Coagulopathy after liver cryoablation was first reported many years ago; the cause is local platelet trapping and destruction within the margin of the cryolesion. However, the prognosis and therapeutic effects of coagulopathy remain unclear. This study retrospectively reviewed clinical data from 372 patients (525 sessions) who underwent liver cryoablation in our hospital during the past 4.5 years. Small tumors (major diameter < 6 cm) were treated with a single complete ablation; massive tumors (major diameter 6-10 cm or >10 cm) were divided into two or three parts that were dealt with in turn. Platelet counts decreased to an average of (46.12 ± 68.13) × 10(9)/L after each session of cryoablation. The decline was most evident in patients with high pretreatment platelet counts, while those with low pretreatment counts had the highest risk of coagulopathy. Change in platelet count was not correlated with the diameter of the tumor. Slight coagulopathy (platelet count (70-100) × 10(9)/L) can resolve without treatment within 1 week and administration of recombinant human interleukin-11 can assist recovery from severe coagulopathy (platelet count < 70 × 10(9)/L).

摘要

肝冷冻消融术后凝血功能障碍早在多年前就有报道;其原因是在冷冻损伤边缘的局部血小板捕获和破坏。然而,凝血功能障碍的预后和治疗效果仍不清楚。本研究回顾性分析了过去 4.5 年我院 372 例(525 例次)接受肝冷冻消融治疗的患者的临床资料。小肿瘤(最大直径<6cm)采用单次完全消融治疗;大肿瘤(最大直径 6-10cm 或>10cm)分为两部分或三部分依次处理。每次冷冻消融后血小板计数平均下降至(46.12±68.13)×109/L。血小板计数较高的患者下降最为明显,而血小板计数较低的患者发生凝血功能障碍的风险最高。血小板计数的变化与肿瘤的直径无关。轻度凝血功能障碍(血小板计数(70-100)×109/L)无需治疗,可在 1 周内自行缓解,重组人白细胞介素-11 可辅助治疗严重凝血功能障碍(血小板计数<70×109/L)。

相似文献

1
Diagnosis and treatment of coagulopathy following percutaneous cryoablation of liver tumors: experience in 372 patients.经皮冷冻消融治疗肝肿瘤后凝血功能障碍的诊断与治疗:372 例患者的经验。
Cryobiology. 2013 Oct;67(2):146-50. doi: 10.1016/j.cryobiol.2013.06.004. Epub 2013 Jul 4.
2
Biochemical and hematologic alterations following percutaneous cryoablation of liver tumors: experience in 48 procedures.肝肿瘤经皮冷冻消融术后的生化和血液学改变:48例手术经验
Radiology. 2008 Jul;248(1):303-11. doi: 10.1148/radiol.2481061874.
3
Percutaneous imaging-guided cryoablation of liver tumors: predicting local progression on 24-hour MRI.经皮影像引导下肝脏肿瘤冷冻消融术:24 小时 MRI 预测局部进展。
AJR Am J Roentgenol. 2014 Aug;203(2):W181-91. doi: 10.2214/AJR.13.10747. Epub 2014 Feb 20.
4
Local platelet trapping as the cause of thrombocytopenia after hepatic cryotherapy.局部血小板滞留作为肝脏冷冻治疗后血小板减少症的病因
World J Surg. 2005 May;29(5):657-60; discussion 661. doi: 10.1007/s00268-005-7543-4.
5
Clinical experience with cryosurgery for advanced hepatobiliary tumors.晚期肝胆肿瘤冷冻手术的临床经验
J Surg Res. 1998 Mar;75(2):103-8. doi: 10.1006/jsre.1998.5280.
6
Aprotinin inhibits local platelet trapping and improves tissue destruction in hepatic cryosurgery.抑肽酶可抑制肝脏冷冻手术中局部血小板聚集,并减轻组织损伤。
Surgery. 2004 Sep;136(3):624-32. doi: 10.1016/j.surg.2004.02.004.
7
Percutaneous cryoablation of small hepatocellular carcinoma with US guidance and CT monitoring: initial experience.超声引导及CT监测下经皮冷冻消融治疗小肝细胞癌:初步经验
Cardiovasc Intervent Radiol. 2008 May-Jun;31(3):587-94. doi: 10.1007/s00270-008-9293-9. Epub 2008 Jan 31.
8
Vanderbilt experience with cryosurgery for 25 advanced hepatic tumors.范德比尔特大学对25例晚期肝肿瘤进行冷冻手术的经验。
Tenn Med. 1998 Sep;91(9):357-60.
9
Percutaneous comprehensive cryoablation for metastatic hepatocellular cancer.经皮综合冷冻消融治疗转移性肝细胞癌。
Cryobiology. 2013 Feb;66(1):76-80. doi: 10.1016/j.cryobiol.2012.11.008. Epub 2012 Dec 10.
10
Characteristics and surgical outcome of HCC patients with low platelet count.血小板计数低的肝癌患者的特征及手术结果
Hepatogastroenterology. 2012 Oct;59(119):2269-72. doi: 10.5754/hge10649.

引用本文的文献

1
Clinical application status and prospect of the combined anti-tumor strategy of ablation and immunotherapy.消融联合免疫治疗的临床应用现状与展望。
Front Immunol. 2022 Sep 5;13:965120. doi: 10.3389/fimmu.2022.965120. eCollection 2022.
2
Percutaneous Cryoablation for Liver Cancer.经皮冷冻消融治疗肝癌。
J Clin Transl Hepatol. 2014 Sep;2(3):182-8. doi: 10.14218/JCTH.2014.00017. Epub 2014 Sep 15.